-transparent.png){kind=logo}
An analysis of 3,630 gastric cancer cases from 412 institutions who were treated with 6 randomly-assigned protocols was carried out to study the effect of daily PSK and Futraful administration and the adjuvant effect of PSK and/or Picibanil (OK 5 KE) combined with MMC and FT. Evaluation of immunochemotherapy was made on the basis of three-year survival rates and immunoparameters. The most positive results were found in survival rates favoring the combined therapy (FT + PSK) over single administration (FT) to relatively early-stage patients (30%, difference), PSK, MMC and FT combination (10%), and PSK, OK, MMC and FT (22%), over single chemotherapy alone. Serum alpha-2 globulin levels, indicative of immunosuppression, were lower in PSK-administered cases. The overall findings indicated that PSK and/or OK with MMC and FT are effective in prolonging the lives of post-operative patients.
T Nakajima, and
K Inokuchi, and
T Hattori, and
K Inoue, and
T Taguchi, and
T Kondo, and
O Abe, and
K Kikuchi, and
T Tanabe, and
N Ogawa
January 1984,
Gan to kagaku ryoho. Cancer & chemotherapy,
T Nakajima, and
K Inokuchi, and
T Hattori, and
K Inoue, and
T Taguchi, and
T Kondo, and
O Abe, and
K Kikuchi, and
T Tanabe, and
N Ogawa
December 1990,
Gan to kagaku ryoho. Cancer & chemotherapy,
T Nakajima, and
K Inokuchi, and
T Hattori, and
K Inoue, and
T Taguchi, and
T Kondo, and
O Abe, and
K Kikuchi, and
T Tanabe, and
N Ogawa
January 1991,
European journal of cancer (Oxford, England : 1990),
T Nakajima, and
K Inokuchi, and
T Hattori, and
K Inoue, and
T Taguchi, and
T Kondo, and
O Abe, and
K Kikuchi, and
T Tanabe, and
N Ogawa
February 1983,
Gan to kagaku ryoho. Cancer & chemotherapy,
T Nakajima, and
K Inokuchi, and
T Hattori, and
K Inoue, and
T Taguchi, and
T Kondo, and
O Abe, and
K Kikuchi, and
T Tanabe, and
N Ogawa
December 1993,
Gan to kagaku ryoho. Cancer & chemotherapy,
T Nakajima, and
K Inokuchi, and
T Hattori, and
K Inoue, and
T Taguchi, and
T Kondo, and
O Abe, and
K Kikuchi, and
T Tanabe, and
N Ogawa
January 1992,
Anticancer research,
T Nakajima, and
K Inokuchi, and
T Hattori, and
K Inoue, and
T Taguchi, and
T Kondo, and
O Abe, and
K Kikuchi, and
T Tanabe, and
N Ogawa
May 1994,
Lancet (London, England),
T Nakajima, and
K Inokuchi, and
T Hattori, and
K Inoue, and
T Taguchi, and
T Kondo, and
O Abe, and
K Kikuchi, and
T Tanabe, and
N Ogawa
November 1983,
The Japanese journal of surgery,
T Nakajima, and
K Inokuchi, and
T Hattori, and
K Inoue, and
T Taguchi, and
T Kondo, and
O Abe, and
K Kikuchi, and
T Tanabe, and
N Ogawa
September 2011,
Radiation oncology (London, England),
T Nakajima, and
K Inokuchi, and
T Hattori, and
K Inoue, and
T Taguchi, and
T Kondo, and
O Abe, and
K Kikuchi, and
T Tanabe, and
N Ogawa
September 2022,
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology,
